Abstract

The overall objectives and scope of this contract is to advance the development of human monoclonal antibody (mAbs) products for treatment of Influenza A viral infections. The scope of work for this contract includes nonclinical, preclinical, and clinical development activities.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200900014C-0-0-1
Application #
7946118
Study Section
Project Start
2009-08-15
Project End
2014-08-14
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$13,246,602
Indirect Cost

  Institution

Name
Crucell Holland, Bv
Department
Type
DUNS #
415960780
City
Leiden
State
Country
Netherlands
Zip Code
2333 -CN